Tumor promoters: From chemicals to inflammatory proteins

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 10, 2013, Pages 1603-1614

  Fujiki, Hirota ^a   Sueoka, Eisaburo ^b   Suganuma, Masami ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Keywords: Cytokine; Okadaic acid; Reiztheorie; Tip ; TNF ; TPA

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIAL PROTEIN; CARCINOGEN; CATECHOL DERIVATIVE; CHEMICAL AGENT; CHEMOKINE; CYTOKINE; INFLAMMATORY PROTEIN; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCING PROTEIN; TUMOR PROMOTER; UNCLASSIFIED DRUG;

CANCER THERAPY; CARCINOGENESIS; DRUG EFFICACY; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REVIEW; RODENT; SKIN; STOMACH; TEA; TUMOR PROMOTION;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CATECHIN; GASTROINTESTINAL NEOPLASMS; HELICOBACTER INFECTIONS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; NEOPLASMS, EXPERIMENTAL; OKADAIC ACID; ORGAN SPECIFICITY; SKIN NEOPLASMS;

EID: 84884670639     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1455-8     Document Type: Review

References (83)

1. Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, Manova-Todorova K, Leversha M, Hogg N, Seshan VE, Norton L, Brogi E, Massague J (2012) A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150(1):165-178
2. Balmain A, Pragnell IB (1983) Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 303(5912):72-74
3. Berenblum I (1941) The cocarcinogenic action of croton resin. Cancer Res 1:44-50
4. Berenblum I, Shubik P (1947) A new, quantitative, approach to the study of the stages of chemical carcinogenesis in the mouse's skin. Br J Cancer 1(4):383-391
5. Boutwell RK (1977) The role of the induction of ornithine decarboxylase in tumor promotion. In: Hiatt HH, Watson JD, Winsten JA (eds) Origin of human cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 773-783
6. Bruchard M, Mignot G, Derangere V, Chalmin F, Chevriaux A, Vegran F, Boireau W, Simon B, Ryffel B, Connat JL, Kanellopoulos J, Martin F, Rebe C, Apetoh L, Ghiringhelli F (2013) Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat Med 19(1):57-64
7. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257(13):7847-7851
8. Coulon S, Francque S, Colle I, Verrijken A, Blomme B, Heindryckx F, De Munter S, Prawitt J, Caron S, Staels B, Van Vlierberghe H, Van Gaal L, Geerts A (2012) Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. Cytokine 59(2):442-449
9. Daff ME, Doll R, Kennaway EL (1951) Cancer of the lung in relation to tobacco. Br J Cancer 5(1):1-20
10. Delclos KB, Nagle DS, Blumberg PM (1980) Specific binding of phorbol ester tumor promoters to mouse skin. Cell 19(4):1025-1032
11. 3H]phorbol 12-p-azidobenzoate 13-benzoate, a photolabile phorbol ester. Proc Natl Acad Sci USA 80(10):3054-3058
12. DiGiovanni J (1992) Multistage carcinogenesis in mouse skin. Pharmacol Ther 54(1):63-128
13. Duda JE, Lee VM, Trojanowski JQ (2000) Neuropathology of synuclein aggregates. J Neurosci Res 61(2):121-127
14. Endo Y, Shudo K, Okamoto T (1982) Molecular requirements for epigenetic modulators. Synthesis of active fragments of teleocidins and lyngbyatoxin. Chem Pharm Bull 30:3457-3460
15. Fibiger J (1965) Investigations on spiroptera carcinoma and the experimental induction of cancer. In: The Nobel Foundation (ed) Nobel lectures including presentation speeches and laureates'biographies, physiology or medicine 1922-1941. Elsevier Publishing Company, Amsterdam-London-New York, pp 122-150
16. Fujiki H, Suganuma M (1993) Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv Cancer Res 61:143-194
17. Fujiki H, Suganuma M (1994) Tumor necrosis factor-α a new tumor promoter, engendered by biochemical studies of okadaic acid. J Biochem (Tokyo) 115(1):1-5
18. Fujiki H, Suganuma M (2011) Tumor promoters - microcystin-LR, nodularin and TNF-α and human cancer development. Anticancer Agents Med Chem 11:4-18
19. Fujiki H, Suganuma M (2012) Green tea: an effective synergist with anticancer drugs for tertiary cancer prevention. Cancer Lett 324(2):119-125
20. Fujiki H, Sugimura T (1987) New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin. Adv Cancer Res 49:223-264
21. Fujiki H, Mori M, Nakayasu M, Terada M, Sugimura T, Moore RE (1981) Indole alkaloids: dihydroteleocidin B, teleocidin, and lyngbyatoxin A as members of a new class of tumor promoters. Proc Natl Acad Sci USA 78(6):3872-3876
22. Fujiki H, Hecker E, Moore RE, Sugimura T, Weinstein IB (1984a) Cellular interactions by environmental tumor promoters. Jpn Sci Soc Press/VNU Science Press, Tokyo/Utrecht
23. Fujiki H, Suganuma M, Tahira T, Yoshioka A, Nakayasu M, Endo Y, Shudo K, Takayama S, Moore RE, Sugimura T (1984b) Nakahara memorial lecture. New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin. In: Fujiki H, Hecker E, Moore RE, Sugimura T, Weinstein IB (eds) Cellular interactions by environmental tumor promoters. Jpn Sci Soc Press/VNU Science Press, Tokyo/Utrecht, pp 37-45
24. Fujiki H, Tanaka Y, Miyake R, Kikkawa U, Nishizuka Y, Sugimura T (1984c) Activation of calcium-activated, phospholipid-dependent protein kinase (protein kinase C) by new classes of tumor promoters: teleocidin and debromoaplysiatoxin. Biochem Biophys Res Commun 120(2):339-343
25. Fujiki H, Suganuma M, Yoshizawa S, Kanazawa H, Sugimura T, Manam S, Kahn SM, Jiang W, Hoshina S, Weinstein IB (1989) Codon 61 mutations in the c-Harvey-ras gene in mouse skin tumors induced by 7,12-dimethylbenz[a]anthracene plus okadaic acid class tumor promoters. Mol Carcinog 2(4):184-187
26. Fujiki H, Suganuma M, Okabe S, Sueoka E, Suga K, Imai K, Nakachi K (2000) A new concept of tumor promotion by tumor necrosis factor-α, and cancer preventive agents (-)-epigallocatechin gallate and green tea - A review. Cancer Detect Prev 24(1):91-99
27. Fujiki H, Suganuma M, Imai K, Nakachi K (2002) Green tea: cancer preventive beverage and/or drug. Cancer Lett 188:9-13
28. Fujiki H, Imai K, Nakachi K, Shimizu M, Moriwaki H, Suganuma M (2012a) Challenging the effectiveness of green tea in primary and tertiary cancer prevention. J Cancer Res Clin Oncol 138(8):1259-1270
29. Fujiki H, Watanabe T, Suganuma M (2012b) Tumor promotion by TNF-α-inducing protein and its receptor nucleolin in human gastric carcinogenesis by Helicobacter pylori. Trends Cancer Res 8:97-117
30. Fukushima S, Friedell GH, Jacobs JB, Cohen SM (1981) Effect of l-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Cancer Res 41(8):3100-3103
31. Guy GR, Cao X, Chua SP, Tan YH (1992) Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J Biol Chem 267(3):1846-1852
32. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646-674
33. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580):353-356
34. Hecker E (1967) Phorbol esters from croton oil, chemical nature and biological activities. Naturwissenschaften 54(11):282-284
35. Hecker E, Adolf W, Hergenhahn R, Schmidt R, Sorg B (1984) Irritant diterpene ester promoters of mouse skin: contributions to etiologies of environmental cancer and to biochemical mechanisms of carcinogenesis. In: Fujiki H, Hecker E, Moore RE, Sugimura T, Weinstein IB (eds) Cellular interactions by environmental tumor promoters. Jpn Sci Soc Press/VNU Science Press, Tokyo/Utrecht, pp 3-36
36. Hennings H, Shores R, Wenk ML, Spangler EF, Tarone R, Yuspa SH (1983) Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters. Nature 304(5921):67-69
37. Itai A, Kato Y, Tomioka N, Iitaka Y, Endo Y, Hasegawa M, Shudo K, Fujiki H, Sakai S (1988) A receptor model for tumor promoters: rational superposition of teleocidins and phorbol esters. Proc Natl Acad Sci USA 85(11):3688-3692
38. Ito N, Fukushima S, Tsuda H, Shirai T, Tatematsu M, Imaida K (1984) Modification of chemical carcinogenesis by antioxidants. In: Fujiki H, Hecker E, Moore RE, Sugimura T, Weinstein IB (eds) Cellular interactions by environmental tumor promoters. Jpn Sci Soc Press/VNU/Science Press, Tokyo/Utrecht, pp 381-389
39. Kakizoe T, Nishio Y, Honma Y, Niijima T, Sugimura T (1984) l-isoleucine and l-leucine are promoters of bladder cancer in rats. In: Fujiki H, Hecker E, Moore RE, Sugimura T, Weinstein IB (eds) Cellular interactions by environmental tumor promoters. Jpn Sci Soc Press/VNU Science Press, Tokyo/Utrecht, pp 373-380
40. Kishimoto T (1989) The biology of interleukin-6. Blood 74(1):1-10
41. Kitagawa T, Sugano H (1978) Enhancing effect of phenobarbital on the development of enzyme-altered islands and hepatocellular carcinomas initiated by 3′-methyl-4-(dimethylamino)azobenzene or diethylnitrosamine. Gann 69:679-689
42. Kitagawa T, Kayano T, Mikami K, Watanabe R, Sugano H (1984) Promotion of hepatocarcinogenesis in vivo and in vitro. In: Fujiki H, Hecker E, Moore RE, Sugimura T, Weinstein IB (eds) Cellular interactions by environmental tumor promoters. Jpn Sci Soc Press/VNU Science Press, Tokyo/Utrecht, pp 337-348
43. Komori A, Yatsunami J, Suganuma M, Okabe S, Abe S, Sakai A, Sasaki K, Fujiki H (1993) Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation. Cancer Res 53(9):1982-1985
44. Mottram JC (1944) A developing factor in experimental blastogenesis. J Pathol Bacteriol 56:181-187
45. Nakamura A, Shirai T, Ogawa K, Wada S, Fujimoto NA, Ito A, Ito N (1990) Promoting action of prolactin released from a grafted transplantable pituitary tumor (MtT/F84) on rat prostate carcinogenesis. Cancer Lett 53(2-3):151-157
46. Nishiwaki-Matsushima R, Ohta T, Nishiwaki S, Suganuma M, Kohyama K, Ishikawa T, Carmichael WW, Fujiki H (1992) Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. J Cancer Res Clin Oncol 118(6):420-424
47. Nishizuka Y (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308(5961):693-698
48. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN (1994) Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 29(5):425-429
49. Ohta T, Sueoka E, Iida N, Komori A, Suganuma M, Nishiwaki R, Tatematsu M, Kim SJ, Carmichael WW, Fujiki H (1994) Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver. Cancer Res 54(24):6402-6406
50. Peraino C, Fry RJM, Staffeldt E (1971) Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2- acetylaminofluorene. Cancer Res 31(10):1506-1512
51. Schmidt R, Sorg B, Marston A, Hecker E (1983) Bivalent and photoaffinity-labeled ligands to study specific binding sites of phorbol esters in mouse epidermis. J Cancer Res Clin Oncol 105:A26
52. Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46(5):705-716
53. Shimizu N, Inada K, Nakanishi H, Tsukamoto T, Ikehara Y, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M (1999) Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 20(4):669-676
54. Shimizu M, Fukutomi Y, Ninomiya M, Nagura K, Kato T, Araki H, Suganuma M, Fujiki H, Moriwaki H (2008) Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev 17(11):3020-3025
55. Shurin MR (2013) Dual role of immunomodulation by anticancer chemotherapy. Nat Med 19(1):20-22
56. Somers-Edgar TJ, Scandlyn MJ, Stuart EC, Le Nedelec MJ, Valentine SP, Rosengren RJ (2008) The combination of epigallocatechin gallate and curcumin suppresses ERα-breast cancer cell growth in vitro and in vivo. Int J Cancer 122(9):1966-1971
57. Stearns ME, Wang M (2011) Synergistic effects of the green tea extract epigallocatechin-3-gallate and taxane in eradication of malignant human prostate tumors. Transl Oncol 4(3):147-156
58. Sueoka E, Sueoka N, Okabe S, Kozu T, Komori A, Ohta T, Suganuma M, Kim SJ, Lim IK, Fujiki H (1997) Expression of the tumor necrosis factor-α gene and early response genes by nodularin, a liver tumor promoter, in primary cultured rat hepatocytes. J Cancer Res Clin Oncol 123(8):413-419
59. Suganuma M, Fujiki H, Suguri H, Yoshizawa S, Hirota M, Nakayasu M, Ojika M, Wakamatsu K, Yamada K, Sugimura T (1988) Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 85(6):1768-1771
60. Suganuma M, Fujiki H, Okabe S, Nishiwaki S, Brautigan D, Ingebritsen TS, Rosner MR (1992a) Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity. Toxicon 30(8):873-878
61. Suganuma M, Tatematsu M, Yatsunami J, Yoshizawa S, Okabe S, Uemura D, Fujiki H (1992b) An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats. Carcinogenesis 13(10):1841-1845
62. Suganuma M, Yatsunami J, Yoshizawa S, Okabe S, Fujiki H (1993) Absence of synergistic effects on tumor promotion in CD-1 mouse skin by simultaneous applications of two different types of tumor promoters, okadaic acid and teleocidin. Cancer Res 53(5):1012-1016
63. Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E, Fujiki H (1999) Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res 59(18):4516-4518
64. Suganuma M, Kurusu M, Okabe S, Sueoka N, Yoshida M, Wakatsuki Y, Fujiki H (2001) Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori. Cancer Res 61(17):6356-6359
65. Suganuma M, Okabe S, Kurusu M, Iida N, Ohshima S, Saeki Y, Kishimoto T, Fujiki H (2002) Discrete roles of cytokines, TNF-α, IL-1, IL-6 in tumor promotion and cell transformation. Int J Oncol 20(1):131-136
66. Suganuma M, Kurusu M, Suzuki K, Nishizono A, Murakami K, Fujioka T, Fujiki H (2005) New tumor necrosis factor-α-inducing protein released from Helicobacter pylori for gastric cancer progression. J Cancer Res Clin Oncol 131(5):305-313
67. Suganuma M, Yamaguchi K, Ono Y, Matsumoto H, Hayashi T, Ogawa T, Imai K, Kuzuhara T, Nishizono A, Fujiki H (2008) TNF-α-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells. Int J Cancer 123(1):117-122
68. Suganuma M, Saha A, Fujiki H (2011) New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci 102(2):317-323
69. Suganuma M, Watanabe T, Yamaguchi K, Takahashi A, Fujiki H (2012) Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pylori. Cancer Lett 322(2):133-138
70. Takahashi M, Hasegawa R, Furukawa F, Toyoda K, Sato H, Hayashi Y (1986) Effects of ethanol, potassium metabisulfite, formaldehyde and hydrogen peroxide on gastric carcinogenesis in rats after initiation with N-methyl-N'-nitro-N- nitrosoguanidine. Jpn J Cancer Res 77(2):118-124
71. Takai A, Bialojan C, Troschka M, Ruegg JC (1987) Smooth muscle myosin phosphatase inhibition and force enhancement by black sponge toxin. FEBS Lett 217(1):81-84
72. Thévenin C, Kim SJ, Rieckmann P, Fujiki H, Norcross MA, Sporn MB, Fauci AS, Kehrl JH (1990) Induction of nuclear factor-κB and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A. New Biol 2(9):793-800
73. Topping DC, Nettesheim P (1980) Two-stage carcinogenesis studies with asbestos in Fischer 344 rats. J Natl Cancer Inst 65:627-630
74. Tsutsui H (1918) Über das künstlich erzeugte Cancroid bei der Maus. Gann 1(XII): 17-21
75. Van Duuren BL (1969) Tumor-promoting agents in two-stage carcinogenesis. Prog Exp Tumor Res 11:31-68
76. Virchow R (1858) Reizung und Reizbarkeit. Arch pathol Anat u Physiol u klin Medizin 14:1-63
77. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319(9):525-532
78. Watanabe K, Reddy BS, Wong CQ, Weisburger JH (1978) Effect of dietary undegraded carrageenan on colon carcinogenesis in F344 rats treated with azoxymethane or methylnitrosourea. Cancer Res 38(12):4427-4430
79. Watanabe T, Tsuge H, Imagawa T, Kise D, Hirano K, Beppu M, Takahashi A, Yamaguchi K, Fujiki H, Suganuma M (2010) Nucleolin as cell surface receptor for tumor necrosis factor-α inducing protein: a carcinogenic factor of Helicobacter pylori. J Cancer Res Clin Oncol 136(6):911-921
80. Yamagiwa K, Ichikawa K (1915) Experimentelle Studie über die Pathogenese der Epithelialgeschwülste. Mitteilungen Med Fakultät Kaiserl Univ Tokyo 15:295-344
81. Yoshida T (1956) Cancer research in Japan. Cancer Res 16(11):1007-1008
82. Yoshida M, Wakatsuki Y, Kobayashi Y, Itoh T, Murakami K, Mizoguchi A, Usui T, Chiba T, Kita T (1999) Cloning and characterization of a novel membrane-associated antigenic protein of Helicobacter pylori. Infect Immun 67(1):286-293
83. Yoshizawa S, Matsushima R, Watanabe MF, Harada K, Ichihara A, Carmichael WW, Fujiki H (1990) Inhibition of protein phosphatases by microcystins and nodularin associated with hepatotoxicity. J Cancer Res Clin Oncol 116(6):609-614